Saralasin (1-sar-8-ala-angiotensin II): pharmacology and clinical use in angiotensin-dependent hypertension.
D000311:Adrenal Glands / Q000187:drug effects; D000450:Aldosterone / Q000378:metabolism; D000804:Angiotensin II / Q000031:analogs & derivatives* / Q000378:metabolism*; D000818:Animals; D001011:Aorta / Q000187:drug effects; D003106:Colon / Q000187:drug effects; D006321:Heart / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy / Q000378:metabolism*; D066298:In Vitro Techniques; D008168:Lung / Q000187:drug effects; D012083:Renin / Q000097:blood; D012504:Saralasin / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D013270:Stomach / Q000187:drug effects; D013894:Thirst / Q000187:drug effects
D000804:Angiotensin II; D000450:Aldosterone; D012083:Renin; D012504:Saralasin